AMSF

AMERISAFE (AMSF) has posted nine consecutive quarters of premium growth with voluntary premiums up 5.7% and renewal retention above 93%, supported by disciplined underwriting in high-hazard industries. However, the stock has underperformed significantly, declining 30.6% in three months.

Key headwinds include rising claims costs, declining workers' compensation rates, and reduced reserve development, which could pressure underwriting results. The company maintains strong financial flexibility with $771 million in investments and returned capital through dividends and share buybacks.

Globe Life reported Q3 2026 earnings of $4.84 per share, missing the consensus estimate of $4.87 and falling short on revenues. The company received a Zacks Rank #3 (Hold) rating, suggesting market-in-line performance ahead. The Insurance - Accident and Health industry ranks in the bottom 16% of Zacks industries, which may pressure stock performance.